BerandaTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Tutup sebelumnya
₹878,10
Rentang hari
₹868,00 - ₹904,20
Rentang tahun
₹571,40 - ₹1.055,00
Kapitalisasi pasar
47,41Â M INR
Volume Rata-Rata
175,69Â rb
Rasio P/E
52,38
Hasil dividen
-
Bursa utama
NSE
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,74Â M | 12,72% |
Biaya operasional | 517,30Â jt | 38,95% |
Laba bersih | 219,50Â jt | 23,45% |
Margin laba bersih | 12,62 | 9,45% |
Penghasilan per saham | 4,16 | 17,51% |
EBITDA | 576,75Â jt | 82,36% |
Tarif pajak efektif | 54,08% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,56Â M | 6,73% |
Total aset | 6,76Â M | 5,04% |
Total liabilitas | 1,39Â M | 19,78% |
Total ekuitas | 5,37 M | — |
Saham yang beredar | 52,64 jt | — |
Harga terhadap nilai buku | 8,61 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 20,54% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 219,50Â jt | 23,45% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Didirikan
1996
Kantor pusat
Situs
Karyawan
1.693
